- Home
- PULM vs HHS Comparison
PULM vs HHS Comparison
Compare PULM & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- HHS
- Stock Information
- Founded
- PULM 2003
- HHS 1923
- Country
- PULM United States
- HHS United States
- Employees
- PULM N/A
- HHS 2003
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- HHS Advertising
- Sector
- PULM Health Care
- HHS Consumer Discretionary
- Exchange
- PULM Nasdaq
- HHS Nasdaq
- Market Cap
- PULM 33.2M
- HHS 28.4M
- IPO Year
- PULM N/A
- HHS N/A
- Fundamental
- Price
- PULM $6.21
- HHS $3.36
- Analyst Decision
- PULM
- HHS
- Analyst Count
- PULM 0
- HHS 0
- Target Price
- PULM N/A
- HHS N/A
- AVG Volume (30 Days)
- PULM 55.4K
- HHS 29.7K
- Earning Date
- PULM 08-12-2025
- HHS 08-07-2025
- Dividend Yield
- PULM N/A
- HHS N/A
- EPS Growth
- PULM N/A
- HHS N/A
- EPS
- PULM N/A
- HHS N/A
- Revenue
- PULM $1,921,000.00
- HHS $181,355,000.00
- Revenue This Year
- PULM N/A
- HHS $6.54
- Revenue Next Year
- PULM $134.88
- HHS N/A
- P/E Ratio
- PULM N/A
- HHS N/A
- Revenue Growth
- PULM N/A
- HHS N/A
- 52 Week Low
- PULM $1.78
- HHS $3.24
- 52 Week High
- PULM $10.40
- HHS $8.52
- Technical
- Relative Strength Index (RSI)
- PULM 41.32
- HHS 32.88
- Support Level
- PULM $6.10
- HHS $3.37
- Resistance Level
- PULM $6.83
- HHS $4.03
- Average True Range (ATR)
- PULM 0.33
- HHS 0.28
- MACD
- PULM -0.05
- HHS -0.02
- Stochastic Oscillator
- PULM 21.00
- HHS 1.80
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.